SMTL ID : 8bw6.1

Titin FnIII-domain I110 (I/A6) from the MIR region

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: E.88, P.89, Y.91 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.88, A:Y.91 EDO.2: 3 residues within 4Å: Chain A: M.55, D.56, F.57 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.56 EDO.3: 4 residues within 4Å: Chain A: T.37, Y.39, T.59, D.60 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.59 EDO.6: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) EDO.7: 1 residues within 4Å: Chain A: D.67 No protein-ligand interaction detected (PLIP) EDO.8: 1 residues within 4Å: Chain A: D.29 No protein-ligand interaction detected (PLIP) EDO.9: 5 residues within 4Å: Chain A: P.27, P.28, D.31, P.35, L.36 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.31, A:D.31, A:L.36

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.4: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

1 x CA: CALCIUM ION(Non-covalent)

CA.5: 2 residues within 4Å: Chain A: D.60, E.62 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.60, A:D.60, A:E.62, H2O.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stergiou, C. et al., Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines (2023)

Release Date

2023-02-15

Peptides

Titin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Titin